Glycoprotein IIb/IIIa receptor inhibitors in combination with vorapaxar, a platelet thrombin receptor antagonist, among patients with non-ST-segment elevation acute coronary syndromes (from the TRACER trial)

American Journal of Cardiology

Volumn 115, Issue 10, 2015, Pages 1325-1332

  Cornel, Jan H ^a   Tricoci, Pierluigi ^b   Lokhnygina, Yuliya ^b   Moliterno, David J ^c   Wallentin, Lars ^d   Armstrong, Paul W ^e   Aylward, Philip E ^f   Clare, Robert M ^b   Chen, Edmond ^g   Leonardi, Sergio ^h   Van De Werf, Frans ⁱ   White, Harvey D ^j   Held, Claes ^d   Strony, John ^k   Mahaffey, Kenneth W ^l   Harrington, Robert A ^l  

^a Medical Centre Alkmaar   (Netherlands)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UPPSALA CLINICAL RESEARCH CENTER   (Sweden)

^e UNIVERSITY OF ALBERTA   (Canada)

^f FLINDERS UNIVERSITY   (Australia)

^g Bayer HealthCare Pharmaceuticals Inc   (United States)

^h FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

ⁱ UNIVERSITY OF LEUVEN   (Belgium)

^j AUCKLAND CITY HOSPITAL   (New Zealand)

^k MERCK RESEARCH LABORATORIES   (United States)

^l STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; EPTIFIBATIDE; PLACEBO; TIROFIBAN; VORAPAXAR; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR; LACTONE; PYRIDINE DERIVATIVE; THROMBIN RECEPTOR;

ADULT; AGED; ARTICLE; BLEEDING; CARDIAC PATIENT; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ACUTE CORONARY SYNDROME; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG COMBINATION; ELECTROCARDIOGRAPHY; FOLLOW UP; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; TIME; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LACTONES; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PYRIDINES; RECEPTORS, THROMBIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84928582964     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.02.043     Document Type: Article

References (18)

1. P. Tricoci, Z. Huang, C. Held, D.J. Moliterno, P.W. Armstrong, F. Van de Werf, H.D. White, P.E. Aylward, L. Wallentin, E. Chen, Y. Lokhnygina, J. Pei, S. Leonardi, T.L. Rorick, A.M. Kilian, L.H. Jennings, G. Ambrosio, C. Bode, A. Cequier, J.H. Cornel, R. Diaz, A. Erkan, K. Huber, M.P. Hudson, L. Jiang, J.W. Jukema, B.S. Lewis, A.M. Lincoff, G. Montalescot, J.C. Nicolau, H. Ogawa, M. Pfisterer, J.C. Prieto, W. Ruzyllo, P.R. Sinnaeve, R.F. Storey, M. Valgimigli, D.J. Whellan, P. Widimsky, J. Strony, R.A. Harrington, and K.W. Mahaffey Thrombin-receptor antagonist vorapaxar in acute coronary syndromes N Engl J Med 366 2012 20 33
2. S. Leonardi, P. Tricoci, and K.W. Mahaffey Promises of PAR-1 inhibition in acute coronary syndrome Curr Cardiol Rep 14 2012 32 39
3. C.W. Hamm, J.P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, P. Caso, D. Dudek, S. Gielen, K. Huber, M. Ohman, M.C. Petrie, F. Sonntag, M.S. Uva, R.F. Storey, W. Wijns, and D. Zahger ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2999 3054
4. J.L. Anderson, C.D. Adams, E.M. Antman, C.R. Bridges, R.M. Califf, D.E. Casey Jr., W.E. Chavey II, F.M. Fesmire, J.S. Hochman, T.N. Levin, A.M. Lincoff, E.D. Peterson, P. Theroux, N.K. Wenger, R.S. Wright, H. Jneid, S.M. Ettinger, T.G. Ganiats, A.M. Lincoff, G.J. Philippides, and J.P. Zidar 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 127 2013 e663 e828
5. S.R. Mehta, C.B. Granger, W.E. Boden, P.G. Steg, J.P. Bassand, D.P. Faxon, R. Afzal, S. Chrolavicius, S.S. Jolly, P. Widimsky, A. Avezum, H.J. Rupprecht, J. Zhu, J. Col, M.K. Natarajan, C. Horsman, K.A. Fox, and S. Yusuf Early versus delayed invasive intervention in acute coronary syndromes N Engl J Med 360 2009 2165 2175
6. G.W. Stone, M.E. Bertrand, J.W. Moses, E.M. Ohman, A.M. Lincoff, J.H. Ware, S.J. Pocock, B.T. McLaurin, D.A. Cox, M.Z. Jafar, H. Chandna, F. Hartmann, F. Leisch, R.H. Strasser, M. Desaga, T.D. Stuckey, R.B. Zelman, I.H. Lieber, D.J. Cohen, R. Mehran, and H.D. White Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY timing trial JAMA 297 2007 591 602
7. R.P. Giugliano, J.A. White, C. Bode, P.W. Armstrong, G. Montalescot, B.S. Lewis, A. van 't Hof, L.G. Berdan, K.L. Lee, J.T. Strony, S. Hildemann, E. Veltri, F. Van de Werf, E. Braunwald, R.A. Harrington, R.M. Califf, and L.K. Newby Early versus delayed, provisional eptifibatide in acute coronary syndromes N Engl J Med 360 2009 2176 2190
8. A. Kastrati, J. Mehilli, F.J. Neumann, F. Dotzer, J. ten Berg, H. Bollwein, I. Graf, M. Ibrahim, J. Pache, M. Seyfarth, H. Schühlen, J. Dirschinger, P.B. Berger, and A. Schömig Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial JAMA 295 2006 1531 1538
9. R. Mehran, S.J. Pocock, G.W. Stone, T.C. Clayton, G.D. Dangas, F. Feit, S.V. Manoukian, E. Nikolsky, A.J. Lansky, A. Kirtane, H.D. White, A. Colombo, J.H. Ware, J.W. Moses, and E.M. Ohman Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial Eur Heart J 30 2009 1457 1466
10. S.V. Rao, J.A. Eikelboom, C.B. Granger, R.A. Harrington, R.M. Califf, and J.P. Bassand Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1193 1204
11. S.V. Manoukian, F. Feit, R. Mehran, M.D. Voeltz, R. Ebrahimi, M. Hamon, G.D. Dangas, A.M. Lincoff, H.D. White, J.W. Moses, S.B. King III, E.M. Ohman, and G.W. Stone Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial J Am Coll Cardiol 49 2007 1362 1368
12. S.V. Rao, K. O'Grady, K.S. Pieper, C.B. Granger, L.K. Newby, K.W. Mahaffey, D.J. Moliterno, A.M. Lincoff, P.W. Armstrong, F. Van de Werf, R.M. Califf, and R.A. Harrington A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes J Am Coll Cardiol 47 2006 809 816
13. J.W. Eikelboom, S.R. Mehta, S.S. Anand, C. Xie, K.A. Fox, and S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782
14. S.V. Rao, K. O'Grady, K.S. Pieper, C.B. Granger, L.K. Newby, F. Van de Werf, K.W. Mahaffey, R.M. Califf, and R.A. Harrington Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206
15. R.C. Becker, D.J. Moliterno, L.K. Jennings, K.S. Pieper, J. Pei, A. Niederman, K.M. Ziada, G. Berman, J. Strony, D. Joseph, K.W. Mahaffey, F. Van de Werf, E. Veltri, and R.A. Harrington Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study Lancet 373 2009 919 928
16. P. Tricoci, L.K. Newby, V. Hasselblad, D.F. Kong, R.P. Giugliano, H.D. White, P. Théroux, G.W. Stone, D.J. Moliterno, F. Van de Werf, P.W. Armstrong, D. Prabhakaran, S. Rasoul, L. Bolognese, E. Durand, E. Braunwald, R.M. Califf, and R.A. Harrington Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic review of randomized clinical trials Circ Cardiovasc Qual Outcomes 4 2011 448 458
17. J.L. Mega, E. Braunwald, S.D. Wiviott, J.P. Bassand, D.L. Bhatt, C. Bode, P. Burton, M. Cohen, N. Cook-Bruns, K.A. Fox, S. Goto, S.A. Murphy, A.N. Plotnikov, D. Schneider, X. Sun, F.W. Verheugt, and C.M. Gibson Rivaroxaban in patients with a recent acute coronary syndrome N Engl J Med 366 2012 9 19
18. R.D. Lopes, S. Subherwal, D.N. Holmes, L. Thomas, T.Y. Wang, S.V. Rao, E. Magnus Ohman, M.T. Roe, E.D. Peterson, and K.P. Alexander The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarction Eur Heart J 33 2012 2044 2053